SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001010412-09-000116
Filing Date
2009-05-20
Accepted
2009-05-20 16:16:27
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2009 sanguineform10qmarch09.htm 10-Q 136994
2 CONSULTING AGREEMENT-LKB PARTNERS lkbconsultingagreement4_3009.htm EX-10 22750
3 CONSULTING AGREEMENT-CORDERMAN garycordconsultingagrfromdav.htm EX-10 21361
4 302 CERTIFICATION OF THOMAS C. DREES ex311.htm EX-31 5910
5 302 CERTIFICATION OF DAVID E. NELSON ex312.htm EX-31 5783
6 906 CERTIFICATION ex32.htm EX-32 4472
  Complete submission text file 0001010412-09-000116.txt   198689
Mailing Address 101 EAST GREEN ST STE 11 PASADENA CA 91105
Business Address 101 EAST GREEN ST #11 PASADENA CA 91105 8184050079
SANGUINE CORP (Filer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24480 | Film No.: 09842745
SIC: 2835 In Vitro & In Vivo Diagnostic Substances